newsfilter
← Latest News
ACCESS Newswire·

Cleveland BioLabs, Inc. Announces $14 Million Registered Direct Offering of Common Stock

Cleveland BioLabs, Inc. (NASDAQ:CBLI), today announced that it has entered into definitive agreements with certain healthcare-focused and institutional investors for the issuance and sale of 2,000,000 shares of its common stock at a purchase price of $7.00 per share in a registered direct offering. The closing of the offering is expected to occur on or about February 23, 2021, subject to the satisfaction of customary closing conditions.